Literature DB >> 3877140

Multiple cancers. Tumor burden permits the outgrowth of other cancers.

C A Mullen, J L Urban, C Van Waes, D A Rowley, H Schreiber.   

Abstract

We demonstrate that tumor-bearing hosts permit the outgrowth of "potentially malignant" cells that are located at a different site. These second cancers continued to grow and kill their hosts even though they retain the "premalignant" phenotype, even after removal of the original malignancy. The potentially malignant cells used in these experiments were ultraviolet light- or methylcholanthrene-induced regressor tumor cells that are rejected regularly by normal mice at any testable dose, and only form progressive tumors in immunosuppressed individuals. The immunological rejection of these highly immunogenic, potentially malignant cells was suppressed by Thy-1+, Ly-2-, nonadherent, radio-sensitive suppressor cells in the tumor-bearing mice. These suppressor cells were absent in nude tumor-bearing mice. Unlike helper and cytolytic T cell-mediated responses, which are exquisitely tumor specific, the suppression caused by a progressively growing tumor was crossreactive among many syngeneic, independently derived tumors induced by different carcinogens. However, T cell-mediated immune responses to alloantigens, allogeneic tumors, certain syngeneic tumors, and humoral responses to xenogeneic red blood cells were normal in these mice. The immune suppression in the tumor-bearing animals closely simulated that induced by ultraviolet light irradiation, and both types of suppression might therefore share common mechanisms. Our findings may contribute to understanding the growth, development, and possible control of multicentric malignancies and add a precaution to the potential use of strongly immunogenic tumor variants for active immunotherapy in hosts bearing less immunogenic tumors.

Entities:  

Mesh:

Year:  1985        PMID: 3877140      PMCID: PMC2187915          DOI: 10.1084/jem.162.5.1665

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

Review 1.  Retinoblastoma: clues to human oncogenesis.

Authors:  A L Murphree; W F Benedict
Journal:  Science       Date:  1984-03-09       Impact factor: 47.728

2.  Multiple primary cancers in 5,456 autopsy cases in the National Cancer Center of Japan.

Authors:  S Watanabe; T Kodama; Y Shimosato; H Arimoto; T Sugimura; K Suemasu; M Shiraishi
Journal:  J Natl Cancer Inst       Date:  1984-05       Impact factor: 13.506

3.  Malignant growth in the normal host after variant selection in vitro with cytolytic T-cell lines.

Authors:  R D Wortzel; J L Urban; H Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

4.  Roentgenographically occult lung cancer. A ten-year experience.

Authors:  D A Cortese; P C Pairolero; E J Bergstralh; L B Woolner; M A Uhlenhopp; J M Piehler; D R Sanderson; P E Bernatz; D E Williams; W F Taylor; W S Payne; R S Fontana
Journal:  J Thorac Cardiovasc Surg       Date:  1983-09       Impact factor: 5.209

5.  Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells.

Authors:  J L Urban; R C Burton; J M Holland; M L Kripke; H Schreiber
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

6.  Immunoselection of tumor cell variants by mice suppressed with ultraviolet radiation.

Authors:  J L Urban; J M Holland; M L Kripke; H Schreiber
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

7.  Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.

Authors:  R J North; I Bursuker
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

8.  Human malignant and mitogen-transformed cells contain retroviral P15E-related antigen.

Authors:  G J Cianciolo; D Phipps; R Snyderman
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

9.  Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine.

Authors:  P Frost; R G Liteplo; T P Donaghue; R S Kerbel
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

10.  Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E.

Authors:  G J Cianciolo; M E Lostrom; M Tam; R Snyderman
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  21 in total

Review 1.  Targeting stroma to treat cancers.

Authors:  Boris Engels; Donald A Rowley; Hans Schreiber
Journal:  Semin Cancer Biol       Date:  2011-12-24       Impact factor: 15.707

2.  Normal inhibition of mammary tumor metastasis in C3H/He mice.

Authors:  J Vaage; D Donovan; T Loftus
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

3.  Prevention by alpha-difluoromethylornithine of skin carcinogenesis and immunosuppression induced by ultraviolet irradiation.

Authors:  H L Gensler
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

4.  Genetic changes occurring in established tumors rapidly stimulate new antibody responses.

Authors:  Michael T Spiotto; Michael A Reth; Hans Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

5.  Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010.

Authors:  Gregory B Lesinski; William E Carson; Elizabeth A Repasky; Wei-zen Wei; Pawel Kalinski; Michael T Lotze; Carl H June; William Petros; Natarajan Muthusamy; Thomas Olencki
Journal:  J Immunother       Date:  2010-09       Impact factor: 4.456

6.  Adoptively transferred immune T cells eradicate established tumors despite cancer-induced immune suppression.

Authors:  Ainhoa Arina; Karin Schreiber; David C Binder; Theodore G Karrison; Rebecca B Liu; Hans Schreiber
Journal:  J Immunol       Date:  2013-12-23       Impact factor: 5.422

Review 7.  The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis.

Authors:  Sandra S McAllister; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2014-08       Impact factor: 28.824

Review 8.  Mouse models in oncoimmunology.

Authors:  Laurence Zitvogel; Jonathan M Pitt; Romain Daillère; Mark J Smyth; Guido Kroemer
Journal:  Nat Rev Cancer       Date:  2016-09-30       Impact factor: 60.716

9.  Metastatic melanoma positively influences pregnancy outcome in a mouse model: could a deadly tumor support embryo life?

Authors:  Rubens H Bollos; Mary U Nakamura; Valderez B V Lapchick; Estela M A F Bevilacqua; Mariangela Correa; Silvia Daher; Márcia M S Ishigai; Miriam G Jasiulionis
Journal:  Clin Exp Metastasis       Date:  2007-10-12       Impact factor: 5.150

10.  Tumor growth and evasion of immune destruction: UV-induced tumors as a model.

Authors:  C A Mullen; H Schreiber
Journal:  Surv Immunol Res       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.